View of Modulation of Circulating Inflammatory Biomarkers by SGLT2 Inhibitors in Diabetic Patients with Acute Myocardial Infarction: A Quantitative Meta-Analysis of Laboratory Evidence

Return to Article Details Modulation of Circulating Inflammatory Biomarkers by SGLT2 Inhibitors in Diabetic Patients with Acute Myocardial Infarction: A Quantitative Meta-Analysis of Laboratory Evidence Download Download PDF